세계 뇌파계/EEG 시스템 시장 규모는 2023년 10억 5,048만 달러, 2030년에는 18억 5,084만 달러에 달할 것으로 예상되며, 2024-2030년 예측 기간 동안 연평균 9.96% 성장할 것으로 예상됩니다. 뇌파계 수요는 주로 간질, 뇌졸중, 혼수 상태, 수면 장애와 같은 신경 질환의 증가로 인해 증가하고 있습니다. 또한, 첨단 혁신 기술의 채택 증가, 노인 인구 증가, 기기 출시 및 승인 증가 등이 2024-2030년 예측 기간 동안 시장의 전반적인 성장에 기여하고 있습니다.
뇌파계/EEG 시스템 시장 역학
뇌파계 시장은 다양한 요인에 의해 제품 수요가 증가하고 있으며, 주요 요인 중 하나는 간질, 경화증, 치매와 같은 다양한 신경 질환의 유병률 증가입니다.
예를 들어, 세계보건기구(WHO)(2023)에 따르면 전 세계적으로 매년 약 500만 명이 간질 진단을 받고 있습니다. 고소득 국가에서는 매년 10만 명당 49명이 간질 진단을 받습니다. 중저소득 국가에서는 이 수치가 10만 명당 139명에 달합니다. 따라서 간질 환자의 증가로 인해 대뇌피질과 뇌심부 구조를 기록해 간질을 진단하는 뇌파계가 필요하게 됩니다. 이처럼 간질 환자의 증가는 예측 연도에 뇌파계의 수요를 증가시킬 것입니다.
또한 뇌졸중은 뇌로 가는 혈액 공급이 감소해 뇌 조직에 산소와 영양이 공급되지 않아 발생합니다. 또한 뇌에 병변이 있는 사람은 병변의 크기와 위치에 따라 뇌파가 비정상적으로 느려질 수 있습니다. 뇌파계는 뇌허혈에 빠르게 반응하여 뇌 기능의 변화를 즉각적으로 감지합니다. 예를 들어, World Stroke Organization(2022)에 따르면 전 세계적으로 연간 1,220만 건의 뇌졸중이 새로 발생하는데, 이는 3초마다 1건씩 발생한다고 합니다. 또한, 이 자료는 4명 중 1명이 일생 동안 뇌졸중을 앓을 것이라고 발표했습니다. 따라서 뇌졸중 환자의 증가는 뇌파계가 이러한 신경 질환을 진단하는 데 도움이되기 때문에 뇌파계에 대한 수요를 증가시킬 것입니다. 따라서 위의 요인들은 2024-2030년 예측 기간 동안 뇌파계 시장의 성장에 기여할 것입니다.
그러나 뇌파계와 관련된 제한 사항과 대체 기기의 존재 등이 뇌파계 시장의 성장을 억제할 수 있습니다.
뇌파계/EEG 시스템 시장 부문별 분석
EEG 시스템 시장의 양식 부문에서 휴대용 장치 카테고리는 2023년에 큰 수익 점유율을 차지할 것으로 예상됩니다. 이는 이 부문이 제공하는 이점에 기인합니다.
예를 들어, 부상이나 질병 후 환자는 뇌와 그 활동을 지속적으로 모니터링해야 합니다. 이러한 경우 뇌의 생리적 상태를 측정하기 위해 휴대용 뇌파계를 사용하는 것이 좋습니다.
또한, 외상성 뇌손상 사례의 증가, 제품 출시, 승인, 합병 등이 휴대용 뇌파계의 수요를 증가시킬 것입니다. 예를 들어, Academy for Multidisciplinary Neurotraumatology(AMN)(2022)에 따르면, 전 세계적으로 매년 6,400만-7,400만 건의 외상성 뇌손상(TBI)이 새로 발생하는 것으로 추정되며, 매년 6,900만 명이 TBI로 고통받고 있다고 합니다. 만 명이 TBI로 고통받고 있습니다. 뇌 손상 후 뇌 활동의 변화를 관찰하기 위해 입원 중 또는 퇴원 후 지속적인 뇌 모니터링이 필요합니다. 이러한 경우, 지속적이고 휴대 가능한 뇌파 모니터링은 조기 신경학적 예후 예측, 가역적 단계에서 이상 징후를 감지하고, 개입을 통해 혜택을 누리고, 신경학적 합병증을 예방하는 데 도움이 될 수 있습니다. 따라서 전 세계적으로 TBI 환자 수가 증가함에 따라 예측 기간 동안 뇌파계에 대한 수요가 증가할 것입니다.
휴대용 뇌파계의 제품 출시와 승인 증가도 이 부문의 수요에 긍정적인 영향을 미칠 것으로 예상됩니다. 예를 들어, 2023년 1월 Compumedics Limited는 다양한 신경 질환의 진단, 환자 치료에 대한 깊은 이해, 일상적인 뇌파 측정 및 장기적인 뇌파 측정에 사용할 수 있는 Okti 시스템의 FDA 승인을 획득했습니다. 휴대용 무선 시스템입니다. 무선 기능을 통해 의사는 환자가 침대를 떠나 있는 동안에도 환자의 생리적 데이터를 모니터링할 수 있어 중요한 임상 이벤트를 확실히 기록할 수 있습니다.
이 보고서는 세계 뇌파계/EEG 시스템 시장에 대해 조사 분석했으며, 시장 규모와 예측, 촉진요인 및 과제, 기업 및 제품 프로파일 등의 정보를 전해드립니다.
Electroencephalography Devices/EEG System Market By Type (EEG Equipment And EEG Accessories), Modality (Portable Device And Non-Portable Device), By Application (Disease Diagnosis, Anaesthesia Monitoring, Sleep Monitoring, And Others), End-User (Hospitals, Home Healthcare, Diagnostic Centers, And Others), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of various neurological diseases and the increasing figures of brain injury across the globe
The global electroencephalography devices or EEG system market was valued at USD 1,050.48 million in 2023, growing at a CAGR of 9.96% during the forecast period from 2024 to 2030 to reach USD 1,850.84 million by 2030. The demand for EEG devices is primarily being boosted by the increasing figures of neurologic disorders such as epilepsy, stroke, coma, sleeping disorders, and others. Further, the rising adoption of advanced and innovative technologies, the increasing geriatric population, the increasing device launches & approval, and others are contributing to the overall growth of the EEG devices market during the forecast period from 2024-2030.
Electroencephalography Devices/EEG System Market Dynamics:
The EEG device market is witnessing a growth in product demand owing to various factors, one of the key factors being the increase in the prevalence of various neurological diseases such as epilepsy, sclerosis, dementia, and others.
For instance, according to World Health Organization (WHO) 2023, globally, an estimated 5 million people were diagnosed with epilepsy each year. In high-income countries, 49 per 100,000 people are diagnosed with epilepsy each year. In low- and middle-income countries, this figure can be as high as 139 per 100,000 people. Therefore, the increasing cases of epilepsy will need an EEG device to diagnose epilepsy as the device records activity from the cortex and the deeper brain structures. Thus, the increasing number of cases of epilepsy will increase the demand for EEG devices in the forecast year.
Furthermore, a stroke occurs when the blood supply to the brain is reduced which prevents brain tissue from getting oxygen and nutrients. Also, people with lesions in their brains may have unusually slow EEG waves, depending on the size and the location of the lesion. The EEG devices are rapidly sensitive to brain ischemia and immediately detect changes in brain function. For instance, according to World Stroke Organization 2022, there were 12.2 million new strokes per year around the world which is 1 in every 3 seconds. The same source also stated that 1 in 4 people will have a stroke in their lifetime. Thus, the increasing stroke cases will increase the demand for EEG devices as these devices aid in the diagnosis of such neurological diseases. Therefore, the above-mentioned factors are contributing to the growth of the EEG device market during the forecast period from 2024-2030.
However, the limitation related to EEG devices, the presence of alternative devices, and others may restrict the EEG device market growth.
Electroencephalography Devices/EEG System Market Segment Analysis:
EEG Device Market by Type (EEG Equipment and EEG Accessories), Modality (Portable Device and Non-Portable Device), Application (Disease Diagnosis, Anesthesia Monitoring, Sleep Monitoring, and Others), End-User (Hospitals, Home Healthcare, Diagnostic Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the modality segment of the EEG System market, the portable devices category is expected to amass a significant revenue share in the year 2023. This can be ascribed to the advantages offered by the segment.
For instance, after any injury or disease, patients need continuous monitoring of the brain and its activity. In such cases, portable EEG devices are advised to measure the physiological condition of the brain.
Further, the increasing cases of traumatic brain injury, product launches, approval, mergers, and others will increase the demand for portable EEG devices. For instance, according to Academy for Multidisciplinary Neurotraumatology (AMN) 2022, it is considered that somewhere around 64 to 74 million new cases of Traumatic brain injury (TBI) occur annually worldwide, in conclusion, 69 million people worldwide suffer a TBI each year. After the brain injury, a person needs continuous monitoring of the brain either in hospital or after hospital discharge, to observe any changes in the brain activity. In such cases, continuous and portable EEG monitoring may help in early neurological prognostication, to detect abnormalities at a reversible stage, to access the benefits of interventions, and to prevent neurological complications. Thus, the increasing number of cases of TBI worldwide will increase the demand for EEG devices during the forecast period.
The increasing product launches and approval for portable EEG devices will also create a positive impact on the demand of this segment. For instance, in January 2023, Compumedics Limited received FDA approval for the OKTI system. The Okti System is intended for use in the diagnosis of various neurological disorders, a deep understanding of patient care, and also be used for routine and long Term EEG. The Okti is a simple, portable, wireless system. The wireless capability gives physicians the option of monitoring a patient's physiological data while the patients are out of bed, helping to ensure they capture critical clinical events on the recording.
Therefore, owing to the advantages offered by portable devices will increase the demand for portable EEG devices thereby, driving the growth of the EEG device market during the forecast period.
North America is expected to dominate the overall Electroencephalography Devices/EEG System Market:
Among all the regions, North America is estimated to account for the largest share of the EEG device market in the year 2023. Owing to the significance of key growth factors such as the rising prevalence of sleep disorders, the growing cases of Alzheimer's disease, the increasing cases of road accidents, and others are driving the North America EEG device market. Furthermore, the increasing geriatric population, high disposable income, sophisticated healthcare infrastructure, and regulatory approval for new devices will also help in the market growth in this region.
The aging population creates an increase in health-related issues, especially in neurological diseases due to the physiological changes that can cause glitches in brain functions, as the hormones and proteins decline with age. Older people often experience decreased blood flow to the brain, which can impair memory and can lead to changes in cognitive skills. Therefore, to prevent any future complications older people need continuous monitoring of the brain, which can be provided by an EEG device. For instance, according to the Centers for Disease and Prevention Control (CDC) 2022, by 2040, the number of older adults in the United States is expected to reach 80.8 million. By 2060, it will reach 94.7 million, and older adults will make up nearly 25% of the US population. Thus, the increasing geriatric population in the US will increase the demand for EEG devices as elderly patients may need to use EEG devices for continued monitoring of the brain's activity which can help to diagnose any chronic changes in the brain and to prevent stroke or other life-threatening conditions. Thus, the increasing geriatric population in North America will increase the demand for EEG devices during the forecast period.
Further, in sleep apnea the extracted signals from EEG allow a person to monitor brain activities and diagnose sleep disorders such as insomnia, narcolepsy-cataplexy syndrome, and obstructive sleep apnoea syndrome. For instance, as per the CDC 2022, in 2020, 14.5% of adults had trouble falling asleep most days or every day in the past 30 days in the US. As per the same source, a greater percentage of non-Hispanic White (21.0%) adults had trouble staying asleep most days or every day compared with non-Hispanic Black (15.4%), Hispanic (10.6%), and non-Hispanic Asian (8.7%) adults. Younger adults were less likely to have trouble staying asleep (13.8%) of those aged 18-44) compared with adults aged 45-64 (21.8%). Thus, the increasing population of sleep apnea will increase the demand for EEG devices as these devices are used for continuous monitoring of brain activity and sleeping obstruction.
Coupled with the factors mentioned above, strategic activities such as product launches & approvals, mergers, acquisitions, partnerships, and others also help in boosting regional product demand. For instance, in August 20221 Ceribell, Inc. received FDA approval for Ceribell Instant EEG Headband. The Ceribell Instant EEG Headband is an electroencephalogram (EEG) electrode array intended for single-patient use, it records EEG in patients of 2 years and older. The instant EEG headband is intended for prescription use in the home, healthcare facility, or clinical research environment. Thus, such strategic steps help to increase the demand for EEG devices, thereby driving the North America EEG device market forward during the forecast period.
Electroencephalography Devices/EEG System Market Key Players:
Some of the key market players operating in the EEG devices market include Allengers, Nihon kohden corporation, cadwell industries, magstim EGI, Masimo, Natus Medical Incorporated, NeuroWave System Inc., Seer Medical, Cerbell, Inc., Koninklijke Philips N.V., Compumedics, NeuroSky, Lifelines Neuro, Neurosoft, BrainScope Company Inc, Advanced Brain Monitoring, Inc, EB Neuro S.p.A., g.tec medical engineering GmbH Austria, Bitbrain Technologies, WAVi, and others.
Recent Developmental Activities in the Electroencephalography Devices/EEG System Market:
In January 2023, Bioserenity received FDA approval for Neuronaute with IceCap 2 & IceCap 2 Small. Neuronaute with IceCap2 & IceCap 2 Small, is a system intended to acquire, display, store, archive, and periodically transmit EEG signals from the brain using a full montage array to enable review at a physician's office, hospital, or other remote locations.
In December 2022, Natus Medical completed the previously announced acquisition with Micromed Holdings. Natus Neuro Team will work closely with Micromed management to build upon the Micromed momentum in the European epilepsy market and the emerging presence of Moberg in the ICU.
In December 2021, WAVi Co. received FDA approval for WAVi SCAN EEG System and Accessories. WAVi SCAN is intended for the acquisition, display, and storage, of electrical activity of a patient's brain including electroencephalograph (EEG) and event-related potentials (ERP) obtained by placing two or more electrodes on the head to aid in diagnosis.
In July 2021, Seer medical pty ltd. received FDA approval for Seer Home EEG device. The EEG system Seer Home is intended to acquire, display, and store the electro-physiological signals of the patient's brain obtained by placing electrodes on the patient's scalp.
Key Takeaways from the Electroencephalography Devices/EEG System Market Report Study
Market size analysis for current EEG device market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the EEG device market.
Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the global EEG device market.
Various opportunities available for the other competitor in the EEG device market space.
What are the top-performing segments in 2023? How these segments will perform in 2030.
Which are the top-performing regions and countries in the current EEG device market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for EEG device market growth in the coming future?
Target Audience who can be benefited from this Electroencephalography Devices/Eeg System Market Report Study
EEG device products providers
Research organizations and consulting companies
EEG device-related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders dealing in EEG device
Various End-users who want to know more about the EEG device market and the latest technological developments in the EEG device market.
Frequently Asked Questions For the Electroencephalography Devices/Eeg System Market:
Electroencephalography (EEG) devices, is a medical device that detects abnormalities in brain waves, or the electrical activity in the brain that might be useful in diagnosing various brain disorders, such as epilepsy or seizure.
The device can also help diagnose dementia, sleep disorder, Alzheimer's disease, brain tumors, encephalitis, and others.
The global electroencephalography devices or EEG system market was valued at USD 1,050.48 million in 2023, growing at a CAGR of 9.96% during the forecast period from 2024 to 2030 to reach USD 1,850.84 million by 2030.
The demand for EEG devices is primarily being heightened by the increasing prevalence of neurological diseases such as epilepsy, stroke, Alzheimer's disease, and others. In addition, the advancement in EEG devices, the increasing number of traumatic brain injuries, the rising geriatric population prone to neurological disorders, the increasing device launches & approvals, and others contribute to the overall growth of the EEG device market during the forecast period from 2024-2030.
Some of the key market players operating in the EEG device market include Allengers, Nihon kohden corporation, cadwell industries, magstim EGI, Masimo, Natus Medical Incorporated, NeuroWave System Inc., Seer Medical, Cerbell, Inc., Koninklijke Philips N.V., Compumedics, NeuroSky, Lifelines Neuro, Neurosoft, BrainScope Company Inc, Advanced Brain Monitoring, Inc, EB Neuro S.p.A., g.tec medical engineering GmbH Austria, Bitbrain Technologies, WAVi, and others.
North America is expected to dominate the overall EEG device market during the forecast period from 2024-2030. Factors such as the rising prevalence of sleep disorders, the growing cases of Alzheimer's disease, the increasing geriatric population, and others will create a positive impact on the North America EEG market. Furthermore, high disposable income, sophisticated healthcare infrastructure, regulatory approval for new devices, and increasing awareness about regular monitoring of brain activity will also help in the market growth in this region.